<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>endometrosistreatment - Diplomacy &amp; Trade</title>
	<atom:link href="https://dteurope.com/tag/endometrosistreatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://dteurope.com</link>
	<description>Monthly in print &#124; Daily on the web</description>
	<lastBuildDate>Wed, 18 Feb 2026 13:22:33 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://dteurope.com/wp-content/uploads/cropped-dt_favicon-32x32.png</url>
	<title>endometrosistreatment - Diplomacy &amp; Trade</title>
	<link>https://dteurope.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Richter, FimmCyte to Advance Endometriosis Treatment</title>
		<link>https://dteurope.com/business/richter-fimmcyte-to-advance-endometriosis-treatment/</link>
		
		<dc:creator><![CDATA[D&#38;T]]></dc:creator>
		<pubDate>Wed, 18 Feb 2026 10:19:00 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[endometrosistreatment]]></category>
		<category><![CDATA[fimmcyte]]></category>
		<category><![CDATA[gedeonrichter]]></category>
		<category><![CDATA[healthcare]]></category>
		<guid isPermaLink="false">https://dteurope.com/?p=78108</guid>

					<description><![CDATA[<p>Hungarian pharmaceutical company Gedeon Richter on Wednesday said it signed a strategic research collaboration and option-to-license agreement with Swiss biotech company FimmCyte. Richter said the partnership aims to advance the development of FimmCyte's FMC2 antibody for the treatment of endometriosis. The parties have negotiated an exclusive and worldwide license agreement for the future development and [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://dteurope.com/business/richter-fimmcyte-to-advance-endometriosis-treatment/">Richter, FimmCyte to Advance Endometriosis Treatment</a> appeared first on <a rel="nofollow" href="https://dteurope.com">Diplomacy &amp; Trade</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
